CARLNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

CARLSMED, INC.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026

$13.66+0.25 (+1.86%)

Close on Oct 19, 2026

Market cap: $371.43M
P/E (TTM): –
Dividend yield: –

CARLSMED, INC. income statement

Annual Quarterly TTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31
Revenue	51	27
Cost of Revenue	12	7.12
Gross Profit	38	20
Research & Development	17	14
Selling, General & Admin	52	30
Selling & Marketing	35	21
General & Administrative	17	8.39
Operating Expenses	69	44
Operating Income	-31	-24
Interest Expense	1.43	1.32
Interest & Investment Income	2.70	1.33
Other Non-Operating Income	0.94	-0.14
Income Tax Expense	0	0
Net Income	-30	-24
Preferred Dividends	0.58	0.59
Net Income to Common	-30	-25
EPS (Basic)(per share)	-2.12	-6.11
EPS (Diluted)(per share)	-2.12	-6.11
Shares Outstanding (Basic, Weighted)(shares)	14	4.07
Shares Outstanding (Diluted, Weighted)(shares)	14	4.07
EBITDA	-30	-24

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 76.6%
Operating margin: -61.1%
Net margin: -57.4%
Return on equity, FY2025: -209.9%

Financial strength

Current ratio: 8.84
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 373.0%

Valuation

P/E ratio: –
Price to sales: 5.87
Price to book: 4.41
Dividend yield: –